Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Received: 11 May 2018
Accepted: 15 January 2019
First Online: 7 February 2019
Ethics approval and consent to participate
: Approval to execute the study was received from Quorum Review Independent Review Board on 27 June 2016, as QR# 31726/1. All patients completed and signed statements of informed consent prior to their participation.
: Not applicable.
: Nina Galipeau, Brittany Klooster, and Meaghan Krohe were employees of Adelphi Values at the time this manuscript was written, which received payment from Novartis Pharmaceuticals to assist with manuscript preparation. Dennis Revicki and David Cella were paid consultants to Novartis related to this project.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.